1. Home
  2. IRON vs WT Comparison

IRON vs WT Comparison

Compare IRON & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

N/A

Current Price

$87.40

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Logo WisdomTree Inc.

WT

WisdomTree Inc.

N/A

Current Price

$21.41

Market Cap

3.2B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IRON
WT
Founded
2017
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.2B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
IRON
WT
Price
$87.40
$21.41
Analyst Decision
Strong Buy
Buy
Analyst Count
13
7
Target Price
★ $126.77
$25.71
AVG Volume (30 Days)
1.4M
★ 2.6M
Earning Date
11-05-2026
10-30-2026
Dividend Yield
N/A
★ 0.58%
EPS Growth
N/A
★ 127.27
EPS
N/A
★ 0.46
Revenue
N/A
★ $493,753,000.00
Revenue This Year
N/A
$41.58
Revenue Next Year
N/A
$9.88
P/E Ratio
★ N/A
$45.15
Revenue Growth
N/A
★ 15.43
52 Week Low
$40.00
$10.69
52 Week High
$99.50
$25.91

Technical Indicators

Market Signals
Indicator
IRON
WT
Relative Strength Index (RSI) 65.42 51.03
Support Level $65.04 $18.38
Resistance Level N/A $21.64
Average True Range (ATR) 3.82 0.95
MACD 0.55 0.11
Stochastic Oscillator 97.64 87.81

Price Performance

Historical Comparison
IRON
WT

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About WT WisdomTree Inc.

WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.

Share on Social Networks: